All Biotechnology articles
-
Blog
Lygos appoints chief sustainability officer
Chemicals company Lygos announced the appointment of Chantal Bergeron to chief sustainability officer.
-
Blog
Gelesis Holdings CCO resigns, CEO to take on duties
Biotechnology company Gelesis Holdings disclosed in a public filing that Elliot Maltz, chief financial officer, treasurer, chief compliance officer, and corporate secretary, resigned.
-
Blog
CSL promotes senior vice president to chief sustainability officer
Australia-based global biotechnology company CSL announced the promotion of Jeffrey Ball as its first chief sustainability officer.
-
PremiumM&A lessons from EU’s maximum $476M fine against Illumina
The European Commission imposed maximum disciplinary measures in fining U.S.-based biotechnology company Illumina €432 million (U.S. $476 million) regarding its “gun-jumping” merger with cancer detection company Grail.
-
Blog
Carisma Therapeutics recruits Idorsia Pharmaceuticals CCO for GC post
Carisma Therapeutics announced the appointment of Eric Siegel as general counsel and corporate secretary.
-
Blog
Cartography Biosciences promotes interim COO to chief legal officer
Cartography Biosciences announced the promotion of interim Chief Operating Officer Blaine Templeman to chief administrative and legal officer.
-
Blog
Korro Bio names general counsel
Biotechnology research company Korro Bio announced the appointment of Shelby Walker as senior vice president and general counsel.
-
Blog
GreenLight Biosciences promotes deputy GC to general counsel, CCO
Biotechnology company GreenLight Biosciences announced the promotion of Deputy General Counsel Nina Thayer to general counsel and chief compliance officer.
-
Blog
Bayer promotes head of litigation to general counsel
Life sciences company Bayer announced the promotion of Vice President and Global Head of Litigation William Dodero to senior vice president and general counsel.
-
ArticlePharma, whistleblower lessons learned from $900M Biogen settlement
Experts discuss the ramifications of Biogen’s $900 million settlement for False Claims Act violations, including the $266.4 million whistleblower bounty in the case believed to be the largest single award under any government program.
-
ArticleBiogen finalizes $900M settlement in false claims whistleblower suit
Biogen finalized a $900 million settlement concerning alleged kickbacks it paid to doctors to induce them to prescribe the company’s drugs and not those of its competitors.
-
Article
Cullinan Oncology names chief legal, compliance officer
Biotechnology researcher Cullinan Oncology announced the appointment of Jacquelyn Sumer as chief legal and compliance officer and corporate secretary.
-
Article
DermTech appoints chief compliance officer
Biotechnology research firm DermTech announced the appointment of Jennifer Eilemberg as chief compliance officer.
-
ArticleBiogen discloses $900M agreement in whistleblower kickback suit
Massachusetts-based biotechnology firm Biogen reached a $900 million agreement in principle to resolve a False Claims Act lawsuit brought by a whistleblower alleging the payment of unlawful kickbacks to physicians.
-
Article
Ocugen appoints chief accounting officer
Ocugen, a clinical-stage biopharmaceutical company, announced the appointment of Jessica Crespo as chief accounting officer and senior vice president, finance.
-
Article
Opentrons Labworks names chief legal and compliance officer
Biotechnology company Opentrons Labworks announced the appointment of Veleka Peeples-Dyer as chief legal and compliance officer.
-
ArticleSEC notifies five Chinese companies of HFCAA noncompliance
The Securities and Exchange Commission has notified five China-based public companies they could be delisted from U.S. stock exchanges if they do not allow their audits to be inspected by the Public Company Accounting Oversight Board.
-
Article
Vaxart appoints general counsel
Vaxart, a clinical-stage biotechnology company, appointed Edward Berg as the company’s first in-house general counsel.
-
Article
Veracyte appoints chief accounting officer
Veracyte, a global diagnostics company, has appointed Jonathan Wygant as chief accounting officer.
-
Article
Biocept adds chief compliance officer
Biocept, a provider of molecular diagnostic assays, products, and services, announced the appointment of Darrell Taylor as senior vice president, general counsel and chief compliance officer.